DIFFERENTIAL IMMUNOGENICITY OF VACCINIA AND HIV-1 COMPONENTS OF A HUMAN RECOMBINANT VACCINE IN MUCOSAL AND BLOOD COMPARTMENTS

Mucosal immune responses induced by HIV-1 vaccines are likely critical for prevention. We report a Phase 1 safety and immunogenicity trial in 8 participants using the vaccinia-based TBC-3B vaccine given subcutaneously to determine the relationship between HIV-1 specific systemic and gastrointestinal...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Anton, Peter A., Ibarrondo, F Javier, Boscardin, W. John, Zhou, Ying, Schwartz, Elissa J., Ng, Hwee L., Hausner, Mary Ann, Shih, Roger, Elliott, Julie, Hultin, Patricia M., Hultin, Lance E., Price, Charles, Fuerst, Marie, Adler, Amy, Wong, Johnson T., Yang, Otto O., Jamieson, Beth D.
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2570228/
https://ncbi.nlm.nih.gov/pubmed/18621451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.05.084
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items